Timber Pharmaceuticals Announces All CONTROL Study Sites Open and Enrolling Patients with Moderate to Severe Congenital Ichthyosis

Stock Information for Timber Pharmaceuticals Inc Com (New)

Loading

Please wait while we load your information from QuoteMedia.